XBI ETF Forecast & Price Targets
XBI Analyst Ratings
Strong Buy
147Buy9Hold0Sell
Based on the Wall Street analyst consensus for 156 of XBI’s holdings.
XBI 12 Month Forecast
Average Price Target
$249.17▲(59.74% Upside)Based on Wall Street analyst 12-month price targets for 156 of SPDR S&P BIOTECH ETF’s holdings in the last 3 months. The average price target is $249.17 with a high forecast of $332.31 and a low forecast of $169.98. The average price target represents a 59.74% change from the last price of $155.98.
Past 12 Months12 Month ForecastJan2026Oct2026
High$332.31
Average$249.17
Low$169.98
Highest Price TargetHighest$332.31Average Price Target$249.17Lowest Price TargetLowest$169.98
XBI Stocks With Highest Upside Potential
XBI Stocks With Highest Downside Potential
XBI ETF FAQ
What is XBI’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 156 of XBI’s holdings, SPDR S&P BIOTECH ETF’s 12-month average price target is $249.17.
What is XBI’s upside potential, based on the analysts’ average price target?
XBI’s average price target of $249.17 represents a 59.74% upside from its last price of $155.98.
Is XBI a Buy, Sell or Hold?
SPDR S&P BIOTECH ETF has a consensus rating of Strong Buy, based on the analyst consensus for 156 of XBI’s holdings: 147 rated Buy, 9 rated Hold and 0 rated Sell.
What is SPDR S&P BIOTECH ETF’s price target?
The average price target for SPDR S&P BIOTECH ETF is $249.17, based on Wall Street analyst 12-month price targets for 156 of XBI’s holdings, issued in the past 3 months. The highest price target is $332.31 and the lowest is $169.98. The average price target represents a 59.74% increase from the last price of $155.98.
What is XBI’s expense ratio?
XBI’s expense ratio is 0.35%.
How many holdings does XBI have?
XBI holds 158 assets.
How can I buy shares of XBI?
You can buy shares of XBI through a brokerage account. Compare brokers on our Best Online Brokers page.